Information for Clinicians Brochure
Isoniazid Prophylactic Therapy for the Prevention of Tuberculosis in HIV Infected Adults: A Systematic Review and Meta-Analysis of Randomized Trials | PLOS ONE
Once-weekly rifapentine and isoniazid for tuberculosis prevention in patients with HIV taking dolutegravir-based antiretroviral therapy: a phase 1/2 trial - The Lancet HIV
Isoniazid - TB DRUG MONOGRAPHS
4 months of rifampin for latent TB shows promise
Isoniazid (INH) - Uses, Dose, Side effects, MOA, Brands
Adherence to nine-month isoniazid for latent tuberculosis infection in healthcare workers: a prospective study in a tertiary hospital | Scientific Reports
Treatment options for latent tuberculosis infection - Latent tuberculosis infection: updated and consolidated guidelines for programmatic management - NCBI Bookshelf
LTBI | Features | TB | CDC
Tuberculosis Series: Treatment - EthnoMed
Chapter 5.1 Recommended dosages of TPT medication | TB Knowledge Sharing
Twelve-dose weekly rifapentine plus isoniazid for latent tuberculosis infection: A multicentre randomised controlled trial in Taiwan - ScienceDirect
Treatment For Latent TB(Tuberculosis) Infection Isoniazid (INH) | The Windsor-Essex County Health Unit
Tuberculosis: Insidious But Treatable
Treatment for Latent Tuberculosis (TB) Infection: Isoniazid and Rifapentine (INH-RPT) | National Prevention Information Network | Connecting public health professionals with trusted information and each other
Children with latent TB adhere to rifampin better than isoniazid
A Lazy Person's Guide to Latent Tuberculosis Treatment in Patients with HIV - Southeast AIDS Education & Training Center
Guidelines for the treatment of latent tuberculosis infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020 - American Journal of Transplantation
Tuberculosis: Current Treatments and Investigational Therapies
Table 3 from Treatment of Latent Tuberculosis Infection. | Semantic Scholar
Dosing regimens for tuberculosis | Download Table
